Inpatient: Patients with relapsed/refractory multiple myeloma for the initial step-up dosing cycle only; restricted to hematology service. Consider subsequent repeat step-up doses as non-formulary with case-by-case evaluation. Secure payor authorization for the medication and the admission, prior to drug procurement and patient admission.
Add Formweb to your mobile device
Formulary restriction:
Inpatient: Patients with relapsed/refractory multiple myeloma for the initial step-up dosing cycle only; restricted to hematology service. Consider subsequent repeat step-up doses as non-formulary with case-by-case evaluation. Secure payor authorization for the medication and the admission, prior to drug procurement and patient admission.
Outpatient: Defer to payor clinical criteria.